Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENVISAGE-TAVI AF: Edoxaban vs VKA in AF patients post-TAVI
NCT02943785Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2017; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02943785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943785.